LV-CMV-mCherry-Puro

SKU:BHV22000013
New Research Validated
Overview
Click light‑blue chips for details
LV-CMV-mCherry-Puro is a pre-packaged, ready-to-use lentiviral vector from SignaGen Laboratories that expresses mCherry under the CMV promoter and carries a puromycin resistance marker. Suitable for stable transduction of dividing and non-dividing cells in vitro and in vivo.
Promoter CMV
Reporter/Tag mCherry
Expression Regulation Constitutive
Selection Marker Puromycin
Titer >1E+9 TU/mL
Biosafety Level BSL-2
Options selector
Catalog no. Size
SL100276-25UL 25 uL
SL100276-25ULX2 25 uL x 2
Available Options

Select the variant that best fits your experiment. Availability and lead time may vary by option.

  • Options: Size: 25 uL; 25 uL x 2
  • Lead time: options listed in "Availability Content"; other statuses may take longer.
  • Storage: Store at -80°C; avoid repeated freeze-thaw cycles.
  • Shipping: Ships on dry ice.
  • Upon receipt: store at recommended temperature as soon as possible; avoid repeated freeze-thaw cycles.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Alternative names LV-CMV-mCherry-Puro | LV-CMV-mCherry | LV-mCherry | CMV-mCherry-Puro Lentivirus
Applications
  • Lentiviral Transduction
Purity In vivo grade and OK for both in vitro tissue culture infection and in vivo injection * Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm
Titer >1E+9 TU/mL
Promoter CMV
Reporter/Tag mCherry
Expression regulation Constitutive
Selection marker Puromycin
Biosafety level BSL-2
Storage buffer PBS
Catalog no. (Mfr.) SL100276
Main SKU BHV22000013
Lentiviral Vector

Vector Overview

LV-CMV-mCherry-Puro is a pre-packaged recombinant lentiviral vector that drives expression of mCherry red fluorescent protein under the control of the cytomegalovirus (CMV) immediate-early promoter. The CMV promoter is one of the most widely used strong constitutive promoters in mammalian expression systems. Derived from the human cytomegalovirus immediate-early regulatory region, it drives high-level expression in a broad range of cell types, though expression may undergo silencing in certain primary or stem cell contexts over prolonged culture. mCherry is a bright, monomeric red fluorescent protein with fast maturation kinetics and good photostability. It is spectrally distinct from GFP, enabling dual-color imaging when both reporters are used in the same experiment. The puromycin resistance cassette allows efficient antibiotic selection of successfully transduced cells, enabling rapid generation of stable, enriched cell populations. Lentiviral delivery ensures efficient, stable integration into the host genome of both dividing and non-dividing mammalian cells. LV-CMV-mCherry-Puro is supplied in a ready-to-use format, eliminating the need for vector construction, packaging, and titration.

Technical Details

Catalog No. SL100276
Promoter CMV
Reporter / Tag mCherry
Expression Regulation Constitutive
Selection Marker Puromycin
Titer >1E+9 TU/mL
Storage Buffer PBS
Purity / Grade In vivo grade and OK for both in vitro tissue culture infection and in vivo injection * Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm
Biosafety Level BSL-2
Sizes 25 uL; 25 uL x 2

Applications

  • Lentiviral Transduction: stable delivery of the cassette into dividing and non-dividing cells for long-term expression.

Biosafety

LV-CMV-mCherry-Puro is a pre-packaged lentiviral vector classified as BSL-2. Handle in a certified biosafety cabinet under institutional BSL-2 practices, decontaminate all contact surfaces and waste, and follow local regulations for viral vector work.

Safety & Handling

Store at -80°C; avoid repeated freeze-thaw cycles. Ships on dry ice. Supplied in PBS. For research use only; not for diagnostic or therapeutic use.

Q.What biosafety level is required for LV-CMV-mCherry-Puro?
A.LV-CMV-mCherry-Puro is a lentiviral vector handled at BSL-2. Work in a certified biosafety cabinet, wear appropriate PPE and decontaminate all waste; institutional biosafety approval is typically required.
Q.What titer is supplied and how should MOI be chosen?
A.The vector is supplied at >1E+9 TU/mL functional titer, stated as a minimum. Calculate multiplicity of infection (MOI) from this value and the number of target cells, and optimize MOI empirically for each cell type, since transduction efficiency varies between cell lines and primary cells.
Q.How are transduced cells selected?
A.The cassette includes a puromycin resistance gene. Select transduced cells with a puromycin concentration determined by a kill curve on the parental cells, then maintain the stable pool under selection.
Q.Is expression constitutive or regulated?
A.Expression of the cassette is constitutive under the CMV promoter: no inducer or driver line is needed for the vector itself, and expression persists in daughter cells after integration.
Q.How should the vector be stored and handled?
A.Store at -80°C; avoid repeated freeze-thaw cycles. Ships on dry ice.

Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

Common customization requests

  • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
  • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
  • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
  • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
  • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

Add-ons you can request

  • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
  • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
  • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

What to include in your request

  • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
  • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
  • Promoter, reporter, and selection marker preferences
  • Desired scale and preferred format (aliquots / concentration requests)

Email us at support@biohippo.com or use the Talk to a Scientist request form.

Vargas-Valderrama A, Ponsen A, Gall M, Clay D, Jacques S, Manoliu T, et al. (2022) Endothelial and hematopoietic hPSCs differentiation via a hematoendothelial progenitor. Stem Cell Res Ther, 13(1), 254-254. 10.1186/s13287-022-02925-w

Craig RA, Fox BM, Hu C, Lexa KW, Osipov M, Thottumkara AP, et al. (2022) Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis. J Med Chem, 65(24), 16290-16312. 10.1021/acs.jmedchem.2c01056

Li B (2021) UNDERSTANDING CARDIOMYOCYTE DIFFERENTIATION FROM PLURIPOTENT STEM CELLS. Thesis.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today